Stoneridge (SRI) Misses Q4 EPS by 9c; Offers Guidance

Stoneridge (NYSE: SRI) reported Q4 EPS of $0.11, $0.09 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $231.2 million versus the consensus estimate of $234 million.

GUIDANCE:

Stoneridge sees FY2023 EPS of ($0.10)-$0.10, versus the consensus of $0.48. Stoneridge sees FY2023 revenue of $960-990 million, versus the consensus of $887.9 million.

For earnings history and earnings-related data on Stoneridge (SRI) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Tenon Medical (TNON) Misses Q2 EPS by 395c